Autoimmune Diseases  >>  imatinib  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
imatinib / Generic mfg.
NCT00154336: A Study of Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis.

Completed
2
50
Canada, Europe
Imatinib, Methotrexate, Imatinib Placebo
Novartis Pharmaceuticals
Rheumatoid Arthritis
08/05
08/05

Download Options